$159.76
-6.29-3.79%
Last update: Nov 5, 5:58 PM
Neurocrine Biosciences Inc (NBIX) Stock Price, Quote, News & History
NBIXNASDAQ
Reports of serious adverse events and deaths linked to Neurocrine's VYKAT XR for Prader-Willi syndrome prompt caution.
You can purchase shares of Neurocrine Biosciences (NASDAQ:NBIX) through any online brokerage.
Other companies in Neurocrine Biosciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Neurocrine Biosciences has a consensus price target of $202.36.
The stock price for Neurocrine Biosciences (NASDAQ: NBIX) is $160.0291 last updated November 5, 2026 at 5:58 PM EST.
There are no upcoming dividends for Neurocrine Biosciences.
Neurocrine Biosciences does not have any upcoming earnings scheduled.
There is no upcoming split for Neurocrine Biosciences.
Neurocrine Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions...
